Prostate carcinoma metastatic in the bone
Clinical trials for Prostate carcinoma metastatic in the bone explained in plain language.
Never miss a new study
Get alerted when new Prostate carcinoma metastatic in the bone trials appear
Sign up with your email to follow new studies for Prostate carcinoma metastatic in the bone, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Chemo-Targeted drug combo outsmart Treatment-Resistant prostate cancer?
Disease control Stopped earlyThis phase 2 trial is testing whether giving two chemotherapy drugs (docetaxel and carboplatin) followed by a maintenance drug called rucaparib can help men with metastatic castration-resistant prostate cancer that has specific DNA repair defects. The idea is that the chemo shrin…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Promising combo for prostate cancer halted early
Disease control Stopped earlyThis study looked at adding ribociclib to the standard hormone therapy enzalutamide for men with a certain type of advanced prostate cancer that had spread and no longer responded to hormone therapy alone. The goal was to find the best dose and see if the combination could lower …
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase 1/2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC